(Q33539483)

27 July 2017

1 reference

title

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy (English)

1 reference

27 July 2017

venous thromboembolism

1 reference

Oger E

1

1 reference

PubMed ID

10069408

27 July 2017

Scarabin PY

series ordinal

2

1 reference

27 July 2017

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

14

1 reference

27 July 2017

1

1 reference

27 July 2017

55-61

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199914010-00004

27 July 2017

0 references

cites work

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

12 December 2020

Selecting and appraising studies for a systematic review

1 reference

12 December 2020

Estrogen replacement therapy and the risk of venous thrombosis

1 reference

12 December 2020

Case-control study of venous thromboembolism risk in users of hormone replacement therapy

1 reference

12 December 2020

Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study

1 reference

12 December 2020

Inherited thrombophilia: Part 1

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

12 December 2020

The effect of postmenopausal estrogen therapy on bone density in elderly women

1 reference

12 December 2020

Risk of venous thromboembolism in users of hormone replacement therapy

1 reference

12 December 2020

Perimenopausal hormone replacement therapy. Review of the literature

1 reference

12 December 2020

The Coronary Drug Project. Initial findings leading to modifications of its research protocol

1 reference

12 December 2020

Quantitative methods in the review of epidemiologic literature

1 reference

12 December 2020

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

12 December 2020

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

12 December 2020

Estrogen and coronary heart disease in women

1 reference

12 December 2020

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

1 reference

12 December 2020

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

12 December 2020

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy

1 reference

12 December 2020

The statistical basis of meta-analysis

1 reference

12 December 2020

Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Differential AT III-response to oral and parenteral administration of 17 beta-estradiol

1 reference

12 December 2020

Venous thromboembolic events associated with hormone replacement therapy

1 reference

12 December 2020

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

12 December 2020

Locating and appraising systematic reviews

1 reference

12 December 2020

Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review

1 reference

12 December 2020

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

12 December 2020

Cardiovascular implications of estrogen replacement therapy.

1 reference

12 December 2020

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

12 December 2020

Postmenopausal hormone therapy and mortality.

1 reference

12 December 2020

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

12 December 2020

Hypercoagulable states: molecular genetics to clinical practice

1 reference

12 December 2020

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

12 December 2020

Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

1 reference

12 December 2020

Coagulation activation following estrogen administration to postmenopausal women

1 reference

12 December 2020

10.2165/00002512-199914010-00004

Identifiers

DOI

1 reference

PubMed ID

10069408

Dimensions Publication ID

27 July 2017

0 references

1 reference

PubMed ID

10069408